Demand tailwinds to drive better valuation for industry as well.

Max Healthcare - Impressive Track Record, Robust Outlook To Sustain Re-Rating: Motilal Oswal

The report is based on the agency’s sample of nine listed hospital chains -- Apollo Hospitals, Aster DM Healthcare, Fortis Healthcare, Healthcare Global Enterprises, Krishna Institute of Medical Sciences, Max Healthcare, Narayana Hrudayalaya, Rainbow Children’s Medicare and Shalby Hospital.

Corporate hospitals to see 8-10 pc revenue growth in FY24: Report

Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 610 in its research report dated August 09, 2023.

Buy Max Healthcare Institute; target of Rs 610: Prabhudas Lilladher

Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 650 in its research report dated August 08, 2023.

Buy Max Healthcare; target of Rs 650: Motilal Oswal

A total of 20,508 shares changed hands on the counter till 01:09PM (IST)

Share price of Max Healthcare falls as Sensex drops 198.56 points

​And that has been the case for many-many years now. So the right way to look at it is year on year. So I think year on year, you had an increase as far as EBITDA is concerned, and you had a flat EBITDA as far as sequential quarters are concerned.

Abhay Soi on Max Healthcare’s expansion plans and future outlook

Max Healthcare Q1 earnings: Max Healthcare increased prices by 2-2.5 percent from April 1, which also aided its topline

Max Healthcare Q1 results: Net profit rises 27% to Rs 291 crore

Buzzing stocks of Aurobindo Pharma, BHEL, Ganesha Eco, Oil India, Infosys, Biocon, Adani Enterprises, Delta Corp, Fortis Healthcare, Reliance Industries, ICICI Bank, ICICI Lombard GIC, India Cements, Barbeque, GIC Housing, Max Healthcare, Gland Pharma, Indigo Paints, Policybazaar, Sobha, Tata Chen, …

Stocks to watch on August 7, 2023

Max Healthcare claimed that the term sheet it signed with Touch Healthcare, which owns Care Hospitals along with TPG-backed Evercare Group, had granted it exclusivity in deal negotiations until April 12. However, the owners of Hyderabad-based Care Hospitals were already talking with other buyers on …

Max Healthcare moves Bombay High Court against arbitration award

A news report that claims the WHO is going to declare Aspartame - artificial sweetener - as a possible carcinogenic has soured the taste of those with a sweet tooth who want to watch their waist lines. The report claims that this artificial sweetener may be declared as an ingredient that has a possibility of causing cancer by one body of the WHO on the 14th of July. A closer look at the report though shows that aspartame falls into the second least dangerous category as far as cancer is concerned as per this body and using your mobile phone is possibly as dangerous. So, are such artificial sweeteners enough to reduce the impact of actual sugar? Are they of any user at all?
On India Development Debate, Tamanna Inamdar speaks with Vikas Dandekar, Editor- Pharma and Healthcare, ET Prime; Dr Salil Parkar, Medical Oncologist, Fortis Hiranandani Hospital; Shubhda Bhanot, Chief Diabetes Educator, Max Healthcare Hospital; and Dr. V. Mohan, Chairman, Dr. Mohan's Diabetes Specialities Centre, on the same.
#worldhealthorginzation #aspartame #artificialsweetner #carcinogenic #etnowshow #indiadevelopmentdebate #tamannainamdar
Subscribe To ET Now For Latest Updates On Stocks, Business News, Trading | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow

Pushed via Slike

Aspartame 'Possibly Carcinogenic': Are Artificial Sweeteners Endangering Your Health? | IDD

A total of 35,001 shares changed hands on the counter till 01:01PM (IST)

Share price of Max Healthcare jumps as Sensex drops 64.97 points

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Strong financials and growth story over the years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Max Healthcare is provider of home health care services including  Patient Care, Healthcare Services, and Hospitals.